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 Abstract 
 
Bioactive glasses represent important biomaterials being investigated for the repair and 
reconstruction of diseased bone tissues, since they exhibit outstanding bonding properties to 
human bone. In the present study bioactive glass (type 45S5) nanoparticles (nBG) with a 
mean particle size in the range of 20-60 nm, synthesized by flame spray synthesis, are 
investigated in relation to in vitro bioreactivity in simulated body fluid (SBF) and response to 
osteoblast cells. The structure and kinetics of hydroxyapatite formation in SBF were 
investigated using transmission electron microscopy (TEM), X-ray diffraction (XRD) and 
Fourier-Transform Infrared Spectroscopy (FT-IR) revealing a very rapid transformation (after 
1d) of nBG to nanocrystalline bone-like carbonated HAp. Additionally, calcite is formed after 
1d of SBF immersion due to the high surface reactivity of the nBG particles. In the initial 
state nBG particles were found to exhibit chain-like porous agglomerates of amorphous nature 
which are transformed upon immersion in SBF into compact agglomerates covered by 
hydroxyapatite with a reduced size of the primary nanoparticles. In vitro studies revealed high 
cytocompatibility of nBG with human osteoblast cells, indicated through high 
lactatedehydrogenase (LDH) and mitochondrial activity as well as alkaline phosphatase 
activity. Hence, this study contributes to the understanding of the structure and bioactivity of 
bioactive glass (type 45S5) nanoparticles, providing insights to the phenomena occurring at 
the nanoscale after immersion in SBF. The results are relevant in relation to the understanding 
of the nanoparticles’ bioreactivity required for applications in bone tissue engineering. 
  
1. Introduction 
Due to their attractive biological properties and appropriate mechanical performance bioactive 
glasses, such as standard 45S5 Bioglass® (BG) is being widely considered in the fields of 
bone tissue engineering (Hench et al. 2004), applied as bone graft materials for small bone 
defects as bioactive coatings for orthopedic implants (Gabbi et al. 1995) and as filler particles 
in biopolymer composites (Rezwan et al. 2006; Boccaccini et al. 2005). Bioactive materials 
must possess controlled degradation behavior and kinetics that should synchronize with the 
sequence of cellular changes occurring during new tissue formation (Hench et al. 2004; Gabbi 
et al. 1995; Rezwan et al. 2006). In the field of bone engineering, bioactivity is defined as the 
ability of the material to bond to bone tissue via the formation of a bone-like hydroxyapatite 
(HAp) layer on its surface (Hench 1998; Kokubo et al. 1990). Kokubo (1991) proposed that 
the essential requirement for an artificial material to bond to living bone is the formation of 
bonelike apatite on its surface when it is implanted in the living body and that this in vivo 
formation of HAp can be reproduced in a simulated body fluid (SBF) with ion concentrations 
nearly equal to those of human blood plasma (Kokubo et al. 1990). Despite some critical 
considerations on the validity of the SBF technique, this method continuous to be applied to 
assess the bioactivity behavior of biomaterials (Bohner and Lemaitre 2009). Detailed analysis 
of the surface apatite formed in SBF solution has been investigated by means of several 
methods such as transmission electron microscopy (TEM), scanning electron microscopy 
(SEM), thin-film X-ray diffraction (XRD) and Fourier-Transform Infrared Spectroscopy 
(FTIR) and it has been shown that it is similar to bone material, both in its structure and in its 
composition (Kokubo et al. 1990; Ohtsuki et al. 1995). The rate of HAp formation on 
bioactive glass surfaces depends amongst other factors on the morphology and structure of the 
material. The recently developed nanosized bioactive glass particles (Brunner et al. 2006) 
represent an attractive alternative to glass particles in the micrometer range for hard tissue 
regeneration, since their small particle size makes them ideal for injectable carrier for 
effective introduction into bone defects. Furthermore, their larger surface area should lead to 
increased interface effects, accelerate their interaction with tissue and improve mechanical 
properties when used in compounds (Boccaccini et al. 2010) and, thus, contribute to an 
improved bioactivity, compared to standard µm-sized particles (Brunner et al. 2006; Loher 
2006) making nanoscaled bioactive glass particles very promising for biomedical 
applications. For example, nanoscaled bioactive glass particles (n-BG) have been shown to 
exhibit higher bioactivity, enhanced protein adsorption and to provide significant higher 
stiffness effect when used as filler in P(3HB) matrices (Misra et al. 2008). Moreover, 
nanoscaled sol-gel derived S70 bioactive glass particles containing nano-pores have been 
shown to enhance the interaction with fibrinogen which depends on the nano-sized porosity 
and the dissolution kinetics of the bioactive glass (Lin et al. 2011). Nanoscaled 45S5 bioactive 
glass particles (same as used in this study) were also reported to exhibit antibacterial 
properties (Waltimo et al. 2007) and to have potential for dentin remineralisation 
(Vollenweider et al. 2007; Curtis et al. 2010) when applied to demineralised dentin matrix. 
Despite these obvious advantages and great potential of nano and sub-micron sized bioactive 
glass particles for tissue engineering applications, there are several concerns about bioactive 
glass (and mixed inorganic nanoparticles in general) being applied in the human body, which 
could potentially cause tissue damage or cytotoxicity. Especially for bioactive glasses, which 
are dissolved in physiological medium creating even smaller particles being released in tissue 
or cell surroundings, only little is known about the potential risks for biomedical applications 
(Nel et al. 2009). Labbaf et al. (2011) investigated sub-micron bioactive glass particles 
(SMBGs) of composition, 85 mol% SiO2 and 15 mol% CaO, synthesized by the sol-gel 
process. They observed bioactivity by the formation of hydroxyapatite after immersion for 5 
days in SBF solution and revealed that these particles did not cause any significant 
cytotoxicity on hMSCs (Human mesenchymal stem cells) until 4 days of culture. It was 
shown, however, that the particles caused significant reduction in cell viability after 7 days of 
cell culture. The biological properties of nanosized inorganic bone substitute materials 
cytocompatibility and osteoconductivity are being extensively investigated. It is well-known 
that nanoscaled materials may exhibit very different physical, chemical and biological 
properties compared to µ-sized materials of the same composition. However, the mechanisms 
of nanosized particle-cell interactions are still not fully understood (Nel et al. 2009). The 
plasma membrane of cells is a selectively permeable membrane for small and nonpolar 
molecules such as O2 and CO2, which can diffuse across the lipid bilayer easily. Polar 
molecules such as ions and larger particles (nanosized) are unable to pass the plasma 
membrane on their own. In the case of particles, cells can uptake (Limbach et al. 2005) or 
enclose them in membrane vesicles by the so called endocytosis process (Sahay et al. 2010). 
However, in many cases, particles do not interact with cell membranes. Adsorption of 
proteins on the nanosized particle surface can lead to agglomeration, which prevents its ability 
to the endocytosis process. Furthermore, nonspecific interactions can also lead to bind 
nanosized particles to the extracellular matrix (ECM). In addition, alterations of the ECM 
caused by nanosized particles will also lead in a dramatic change of cell behavior. The 
interaction of nanosized materials and cells is influenced by shape and size as well as 
crystallinity and material composition of the nanoparticles (Nel et al. 2009). Therefore, 
examining the cytotoxic potential of nanoparticles and its correlation with particle 
characteristics is required for assessing the real applicability of the nanoparticles especially in 
the field of bone regeneration. In a previous work it has been shown that bioactive glass 
nanopowders produced by flame spray synthesis exhibit HAp formation after 5 days of 
immersion in SBF as observed by means of Raman spectroscopy, SEM and XRD analysis 
(Brunner et al. 2006). In the present study we provide a systematic and more comprehensive 
investigation of the structure and bioreactivity kinetics occurring on the nanoscale during 
immersion of the nanosized 45S5 bioactive glass particles in SBF for different time points. 
Furthermore, cell culture tests are carried out in order to assess the cytocompatibility of these 
glass particles. The overall aim of this paper is, thus, to provide the understanding of the 
structure and bioactivity occurring on the nanoscale of bioactive glass (type 45S5) 
nanoparticles and to assess the osteoblast cell response of these particles to their future 
applications in bone tissue engineering, dentistry, wound healing and guided nerve 
regeneration. 
 
2. Experimental section 
2.1. Materials 
Nanoscaled bioactive glass particles (type 45S5), nBG, were synthesized by means of flame 
spray synthesis, as described elsewhere (Brunner et al. 2006). Briefly, the synthesis occurred 
by combining and mixing the corresponding liquid metal precursors and feeding the mixture 
into a flame reactor. The nanopowder was collected on a filter mounted above the flame. The 
specific surface area of the obtained nBG is 60 to 80 m2 g-1. As reference material melt-
derived 45S5 micron sized bioactive glass (µBG) with a mean particle size of D50= 10 µm 
was used. For glass fabrication analytical grades of SiO2, Ca3PO4, NaCO3 and CaCO3 were 
mixed and melted in platinum crucible at 1450 °C. The fritted glass was dried and milled 
down to the required particle size (10 µm) using a planetary mill with zirconia jar and zirconia 
milling beads. The properties of the glass powders used are given in Table 1. The chemical 
composition (see Table 2) of the glass samples used was verified by laser ablation inductively 
coupled plasma mass spectroscopy (LA-ICP-MS). 
2.2 In vitro bioactivity testing in simulated body fluid (SBF) 
The in vitro bioactivity of the samples (nBG and µBG) was tested by immersing the glass 
powders in simulated body fluid (SBF). SBF solution was prepared according to Kokubo et 
al. (2006). The pH value of SBF was adjusted to 7.4 at 37.0 °C, by using Tris(hydroxymethyl) 
amino methane and hydrochloric acid. The ionic concentrations of the inorganic components 
are given in Table 3. 75 mg of nBG powder were immersed in 50 ml SBF at 37 °C for 4h, 8h, 
1d, 3d and 7d, respectively. The samples were stirred at 120 rpm using an orbital shaker (KS 
4000i control, IKA, Staufen, Germany). After SBF soaking the nBG powder was filtered, 
gently rinsed with distilled water and dehydrated with acetone. The samples were dried at 60 
°C for 24h before characterization.  
2.3 Cell culture tests 
Cell culture and sample preparation  
To evaluate the cell behaviour of nBG compared with µBG, MG-63 osteoblast-like cells 
(Sigma-Aldrich, Germany) were used. This human osteosarcoma cell line was cultured at 37 
°C in a humidified atmosphere of 95 % air and 5 % CO2, in DMEM (Dulbecco’s modified 
Eagle’s medium, Gibco, Germany) containing 10 vol.% fetal bovine serum (FBS, Sigma-
Aldrich, Germany) and 1 vol.% penicillin/streptomycin (Sigma-Aldrich, Germany). Cells 
were grown for 48 hours to confluence in 75 cm2 culture flasks (Nunc, Denmark), washed 
with phosphate buffered saline (PBS) before harvested using Trypsin/EDTA (Sigma, 
Germany), counted by a hemocytometer (Roth, Germany) and diluted to a final concentration 
of 100.000 cells ml-1. Before cell seeding, the µBG and nBG particles were dispersed in 70% 
ethanol and sonicated for 30-60 min. Then, bioactive glass (BG) containing ethanol 
suspension was transferred into 48 well plates and ethanol was completely evaporated in a 
drying chamber. MG-63 cells were exposed to varying concentrations (0.1, 1, 10, 100 and 200 
µg ml-1) of BG particles present in final volume of 600 µl culture media for 48 hours. The in 
vitro analysis of BG was compared to ZnO particles (Oxiznic Agalsa, Spain) with the same 
concentrations as used for BG. ZnO is the positive control for cytotoxicity in this 
investigation. Therefore, LC50 value (lethal concentration of the used particles where the 
activity of the cells is reduced to 50%) was calculated. During cell incubation and after 48h of 
incubation cell distribution and morphology in contact with BG and ZnO were evaluated 
using phase contrast light microscopy (LM, Nikon Eclipse TE 2000-U, Japan).  
 
LDH-activity  
Lactate dehydrogenase (LDH-) activity gives a measurement of the amount of attached cells 
on the BG. LDH reduces NAD+, which catalyses the conversion of tetrazolium to a coloured 
formazan derivative. A commercially available LDH-activity quantification kit (TOX7, 
Sigma-Aldrich) was used to quantify cell proliferation by enzyme activity in cell lysate. MG-
63 cells cultured in 48-well plates were washed with PBS and lysed with lysis buffer for 10 
minutes (1 ml/well). The lysate solutions were centrifuged by 250 g and 100 µl from the 
supernatant solutions were transferred to a 98-well plate. 30 µl of Master-mix were added to 
each well containing equal amounts of: substrate solution, dye solution and cofactor solution 
for LDH assay. The plates were left for 30 minutes in the dark and the reaction was stopped 
with 40 µl HCl 1 N per well. The dye was measured using a spectrophotometer (SPECORD 
40 BU, analytikjena, Germany) at 490 nm.  
Mitochondrial activity 
For assessing the influence of different BG and ZnO concentrations on the viability of MG-63 
cells after 2 days of culture, a WST-8 assay (Sigma-Aldrich) was used. After a cultivation 
period of 48 hours, the mitochondrial activity of MG-63cells was measured by the conversion 
of tetrazolium (WST-8, Sigma) to formazan by mitochondrial enzymes. Culture media was 
removed from the 48-well wells plates and the cells were washed with PBS. After addition of 
100 µl of solution containing 99 µl culture medium and 1 µl WST-8 in each well, the plates 
were incubated for 1 h. Afterwards the supernatant of all samples was transferred and 
centrifuged by 250 g. Subsequently, the solution was given in a 98-well plates (50 µl in each 
well) to measure the absorbance at 450 nm and 650 nm with an ELISA-Reader (Perkin Elmer, 
Multilabel Reader Enspire 2300, Germany). 
Vybrant™ cell-labeling  
The samples were prepared for confocal scanning laser microscopy (CSLM, Leica TCS SP5 
II, Germany) to analyse cell morphology and distribution. To analyse the adherent growth of 
cells on the bioactive glass samples, Vybrant™ cell-labeling solution (Molecular Probes, The 
Netherlands) was used. After 48 hours of incubation, cell culture medium was removed and 
staining solution (5 µl dye labelling solution to 1 ml of growth medium) was added and 
incubated for 15 min. Afterwards the solution was removed, the samples were washed with 
PBS (phosphate buffered saline, Gibco) and cells on the BG samples were fixed by 3.7 vol.% 
paraformaldehyde.  
Specific Alkaline phosphatase (ALP) activity  
ALP is a membrane-bound metalloenzyme which catalyzes the hydrolysis of 
phosphomonoesters at an alkaline pH. For determining the osteoblastic activity of the MG-63, 
ALP was analysed by measuring the specific enzyme activity after 48 hours of incubation 
with BG. After lysing the cells with a cell lysis buffer containing 20 mM TRIS buffered 
solution (Merck) with 0.1 wt% Triton X-100 (Sigma, Germany), containing 1 mM MgCl2 
(Merck) and 0.1 mM ZnCl2 (Merck), the absorption was measured at 405 nm using a 
spectrometer after 90 min of incubation. The specific activity was then calculated with respect 
to the protein concentration of the cell lysates. Therefore, the protein content of the cell 
lysates was determined using a commercial kit based on Bradford assay (Sigma).  
Statistical analysis 
Each experiment was repeated four times. The results are presented as average and standard 
deviation of four replicates with the values. Samples with 0 µg ml-1 BG and ZnO were set as 
100%. The differences in analysis parameters between the BG concentrations were evaluated 
by one-way analysis of variance (ANOVA). The level of the statistical significance was 
defined at p < 0.05 (Origin 8.1G, OriginLab Corporations, USA). 
2.4 Characterisation techniques 
Transmission electron microscopy (TEM) was carried out using a Phillips CM30 
TWIN/STEM, equipped with an energy dispersive X-ray (EDX) spectroscopy detector for 
analytical analyses. Further TEM investigations are performed using a Titan3 80-300 
equipped with a field-emission gun, an image-side aberration corrector and also an EDX 
detector. TEM images were acquired using charged coupled device (CCD) cameras, having 
an image size of 1024 x 1024 pixels at the CM30 and 2048 x 2048 pixels at the Titan3, 
respectively. Both microscopes were operated at 300 kV acceleration voltage. Furthermore, 
all TEM analyses were performed using a Gatan Model 636-DH double tilt liquid nitrogen 
(LN2) cooled specimen holder, which enables TEM investigations at -170°C specimen 
temperature and prevents damage caused by the electron beam. For TEM investigations, all 
samples were dispersed in a H2O/Ethanol solution and deposited on lacey carbon film coated 
gold grids. 
Fourier-Transform Infrared Spectroscopy (FT-IR) was used to identify the formation of 
reaction phases during the immersion of the samples in SBF. FT-IR spectra of the glass 
powders prior and after soaking in SBF solution were collected in transmission (Impact 420, 
Nicolet Instr., Walthem, MA, US) in the frequency range 400-4000 cm-1 using the KBr 
method. For KBr pellets a sample/KBr ratio of 1/300 was used. The spectra were collected 
accumulating 64 scans with a resolution of 4 cm-1. The spectra were base-line corrected and 
normalized to the main silicate glass peak at ~ 1050 cm-1 in order to compare the intensities of 
the bands within one sample.  
X-ray diffraction (XRD) analysis was used to investigate the structure and phase composition 
present in the bioactive glass samples after immersion in SBF. The XRD data were collected 
with a Bruker D8 Advance powder diffractometer with a graphite secondary monochromator 
using Cu Kα radiation (λ = 0.15406 nm). The XRD patterns were acquired with a step width 
of 0.014 and 1s time per step. The samples were measured over a 2θ range from 20° to 80°. 
As reference, XRD spectra of the as-prepared powders were recorded. 
 
 
 
3. Results 
3.1 In vitro bioactivity 
The kinetics of hydroxyapatite formation on nanoscaled glass particles were monitored by 
FT-IR measurements and compared to micron sized 45S5 powder. The major bands appearing 
in the IR-spectra are summarised in Table 4. Fig. 1 a) shows the FT-IR spectra of the micron-
sized glass (µBG) samples as-received and after immersion in SBF for 4h, 8h, 24h, 3d and 7d. 
For the as-prepared sample without any treatment in SBF the bands at ~500 cm-1 and ~1030 
cm-1 can be assigned to νsym(Si-O-Si) and νasym(Si-O-Si) bands of the SiO4 tetrahedra, 
respectively (Cerruti et al. 2005). Due to the presence of Ca2+ and Na+ cations in the glass 
network the νsym(Si-O-Si) band is shifted to 500 cm-1 compared to pure silica (νsym(Si-O-Si) at 
450) (Bunker et al. 1998). The band at ~930 cm-1 can be attributed to the SiONBO (non-
bonding oxygen, NBO) which is formed through the presence of the glass network modifier, 
creating Si-O groups (Bunker et al. 1998). At ~1450 cm-1 a broad peak is seen which can be 
assigned to the ν3(CO32-)  band of carbonates adsorbed on surfaces (Du et al. 2010). After the 
initial stage of SBF immersion (4h) this single peak is split into two separate bands, but with 
lower intensity at 1430 cm-1 and 1500 cm-1, respectively. With increasing immersion time in 
SBF the intensity of the SiONBO band is decreasing becoming a weak shoulder after 4h of SBF 
immersion which is due to the ion exchange in the glass network and leaching of Na+ and 
Ca2+ ions. Also the νsym(Si-O-Si) band is shifted to 460 cm-1 as observed for pure silica 
(Bunker et al. 1998). At ~ 600 cm-1 a broad peak is observed which can be attributed to 
formation of an amorphous calcium phosphate (ACP) (Hench 1998; Cerruti et al. 2005).  
After 3d of soaking in SBF the SiONBO intensity slightly increases again, whereby the overall 
position of this peak is shifted from 930 cm-1 towards 960 cm-1. This shift is possibly related 
to the higher frequency of SiO absorption as a result of lower content of the NBOs (Cerruti et 
al. 2005). For all stages of the SBF immersion an additional band at ~1210 cm-1 is detected 
which is assigned to ν(Si-O-Si) mode. After 3d immersion the δ(Si-O-Si) band appears at 
~800 cm-1 which is related to the formation of highly disordered 3D silica structure (Cerruti et 
al. 2005). After 3 d of immersion in SBF bending modes of ν4(P-O-P) bond from the PO43- 
group at ~570 cm-1 and ~600 cm-1 are detected. The ν2(P-O-P) bending mode is also observed 
at ~471 cm-1 which, however, is overlapped with the νsym(Si-O-Si) band of the glass network 
(Koutsopoulos 2002). An additional band at 871 cm-1 appearing after 3d of SBF immersion 
can be assigned to ν2(CO32). Moreover, the intensity of the ν2(CO32) bands at 1430 cm-1 and 
1500 cm-1 increased along with increasing SBF immersion time. Fig. 1 b) shows the FT-IR 
spectra for the nanoscaled bioactive glass particles prior and after 4h, 8h, 24h, 3d and 7d 
immersion in SBF. Basically, the spectra exhibit similar characteristic bands as observed for 
µBG. However, the relative intensity and time point of appearance of the absorption bands 
can differ, as documented in Table 4. In the as-prepared state the nBG shows a significantly 
higher intensity of the carbonate signal at 1450 cm-1. Additionally the carbonate band at 871 
cm-1 appears also in the initial state of the sample. After 4h in SBF the intensity of ν2(CO32) 
band drops, but is increasing again with increasing immersion time. Furthermore, the bands at 
800 cm-1 and at ~600 cm-1 appear already after 4h compared to µBG. After 3d a weak 
additional peak at 712 cm-1 is observed which can be attributed to calcite (Bosch et al. 2002). 
For both glasses investigated adsorbed coordinated water molecules were detected on the 
surface (at ~ 1630 cm1-).  
Fig. 2 a) shows the XRD spectra of the as-prepared µBG and after immersion for 1, 3 and 7 
days in SBF. The absence of reflections in the XRD pattern of the as-prepared sample 
confirms the formation of the amorphous structure of the bioactive glass powder. After 1d no 
formation of any crystalline phase is observed, whereas after 3d and 7d the formation of 
carbonated hydroxyapatite, CHAp Ca10(PO4)6(CO3)0.5(OH), (ICDD PDF 2 01-089-4405) is 
detected. The main characteristic peaks of CHA are at 2Θ=26° (002) and 2Θ=31.5° (112).  
Fig. 2 b) shows the XRD spectra of the nBG after 1, 3 and 7 days in SBF. The amorphous 
characteristics of the flame-synthesized nanoscaled bioactive glass was confirmed. After 1 
day a weak signal is detected at 2Θ=31.5° suggesting the formation of CHA. After 3d and 7d 
of immersion formation of CHAp can be clearly seen from the pronounced signals at 2Θ=26° 
and 2Θ=31.5°. Aside from CHAp calcite (ICDD PDF2 01-0713695) is also formed after 3d 
and 7d of immersion in SBF. Using the Scherrer equation the crystallite size Dhkl 
perpendicular to (hkl) lattice planes can be calculated as follows (Danilchenko et al. 2002): !!!" = ! !"#$!!"!"#$    (1) 
Here K, Θ, λ and FWHMhkl are the shape factor, diffraction angle, the wavelength of the x-
rays and the full width at half maximum of the (hkl) peak, respectively. For hydroxyapatite 
and for calcite formed after 7 days in SBF a crystallite size of D112= 5.5 nm and D104=91.4 nm 
were calculated, respectively.  
Fig. 3 a) and b) show bright-field TEM images of the as-prepared nBG. The particles exhibit 
chain-like agglomerates and are structurally amorphous, as confirmed by SAED (inset in Fig. 
3 a)). TEM images show that the primary nanosized glass particles are fused together and 
irregularly shaped, thus making it difficult to make precise conclusions about their size. 
However, the particle size was estimated to be 20 - 60 nm in diameter. Fig. 3 c) – f) shows 
bright- and dark-field TEM images and SAED pattern of nBG after immersion for 1 day in 
SBF. Generally, formation of nanocrystalline HAp and co-precipitation of nanocrystalline and 
coarse calcite is observed, as confirmed by the SAED (insets in Fig. 3 c), d) and e)). The HAp 
found here has a hexagonal crystal structure with P63/m space group symmetry and lattice 
parameters a = b = 0.94 nm, c = 0.69 nm (ICSD_150309). The observed calcite also has a 
hexagonal crystal structure with P63/m space group symmetry and lattice parameters a = b = 
0.49 nm, c = 1.71 nm (ICSD_15879). Unreacted nBG is still present after 1 day in SBF. This 
is evident from the TEM images in Fig. 3 c) and d) showing a network of nanoparticles which 
exhibit shapes being similar to the ones found in the as-prepared sample. Moreover, after 
immersion for 1 day in SBF HAp is also found to precipitate completely separated, as shown 
in Fig. 3 d) and inset in Fig. 3 d). Both DP (insets in Fig. 3 c) and d)) appear blurred, which 
can be attributed to the signal coming from amorphous nBG still being present unreacted. At 
last, after immersion for 1 day in SBF calcite crystals are also found to precipitate separately. 
The DP (inset in Fig. 3 e)) was tilted into the [10-12] zone axis and indicates that this calcite 
is single-crystalline. Dark-field imaging for the (-12-10) reflection (see Fig. 3 f)) reveals the 
location of the calcite crystals.  After immersion of nBG for 7 days in SBF formation of 
calcite and HAp was observed. Fig. 4 a) shows a bright-field TEM image of calcite crystals 
coexisting besides unreacted amorphous nBG. SAED (insets i) and ii) in Fig. 4 a)) confirms 
the hexagonal crystal structure of calcite. On the one hand the SAED pattern (inset i) in Fig. 4 
a)) indicates the presence of single-crystalline calcite (sharp diffraction dots in the pattern), 
where the calcite crystals reach sizes of up to ~ 800 nm in diameter and exhibit irregular 
morphologies. On the other hand, the same SAED pattern shows additional rings besides the 
sharp dots, which indicates the presence of calcite nanocrystals. Thus, a mixture of calcite 
nanocrystals and single crystals is present. Fig. 4 b) shows that the calcite nanocrystals 
surround the bigger calcite crystals, which is evident from the diffraction-contrast of 
crystalline particles being in Bragg-condition. In order to locate the calcite crystals, more 
accurate dark-field TEM imaging was performed within the area marked with the bigger 
dotted circle in Fig. 4 a). The corresponding dark-field images of the (113) and (104) 
reflections are shown in Fig. 4 c) and d). It is worth to mention that during dark-field imaging 
of these two reflections the sharp dots and the corresponding parts of the ring pattern are both 
contributing to the dark-field images (due to the limiting size of the objective aperture), since 
the sharp dots are located exactly on the corresponding reflections of the ring pattern. 
However, these images additionally support that the coarse calcite crystals are surrounded by 
calcite nanocrystals. At last, for the same sample after immersion for 7 days in SBF, 
completely isolated more compact agglomerates (compared to the as-prepared nBG) are 
observed, as shown exemplarily in Fig. 4 e) and f). The agglomerates contain a significant 
amount of HAp, which is confirmed by SAED (inset in Fig. 4 e)). As shown in Fig. 4 f) the 
agglomerates consist of irregularly shaped but also spherical and nearly-spherical particles, 
which reach sizes of 5 - 25 nm in diameter. The transformation of the nBG into HAp and 
calcite is also confirmed by TEM EDX spectroscopy analysis, as shown in the inset of Fig. 4 
b). The EDX spectrum of the as-fabricated nBG shows the typical chemical composition of 
this glass (see inset in Fig. 3 b)). The Ca/P ratio changes from 6.20 for the as-prepared nBG to 
12.06 after immersion in SBF for 7 days. Moreover, a significant decrease of the sodium 
concentration is observed.  
3.2 Results of the in vitro investigation  
Fig. 5 shows the LDH-activity of MG-63 cells cultured on µBG, nBG and ZnO in the range of 
0-200 µg ml-1 over 48 h. ZnO particles induced a reduction in cell viability at higher 
concentrations. Thus the calculated LC50 value for ZnO is approx. 31 µg ml-1. Both µBG and 
nBG exhibit no reduced LDH-activity even at high concentration of 200 µg ml-1. At the 
concentrations of 0.1-100 µg ml-1 significant higher amount of MG-63cells grew on nBG 
compared to µBG.The cell viability of MG-63 cells cultured on µBG, nBG and ZnO in the 
range of 0-200 µg ml-1 over 48 h measured by mitochondrial activity is shown in Fig. 6. In 
case of ZnO there is an optimum concentration of 0.1 µg ml-1 for cell viability. The LC50 
value was determined to be 41 µg ml-1. Again, for µBG and nBG, no reduction in cell 
viability was found. Comparing the two BG samples, 10 and 100 µg ml-1 concentrations of 
nBG induced a significant higher viability in MG-63 cells. MG-63 cells expressed mainly 
elongated and polygonal phenotype and an almost dense cell layer in the cell culture dish after 
48 h of cultivation. LM-images of the MG-63 cell morphology grown on ZnO, Fig. 7 a), 
confirmed the LDH- and mitochondrial activity measurements. The cell layer at 0.1 µg ml-1 is 
most dense and cells are most vital, which can be correlated with results in Fig. 6. 
Furthermore, at the ZnO concentration 10 - 200 µg ml-1 reduction of cells can be seen and 
changes in the morphology of MG-63 cells are observed, which become round. At the highest 
concentration, 200 µg ml-1 agglomeration of ZnO particles and no cells could be detected.  
Morphology analysis of MG-63 cells in contact with different µBG concentrations confirmed 
also the LDH- and mitochondrial activity measurements. The LM-images in Fig. 7 b) 
demonstrate no influence of µBG on MG-63 cell morphology. Compared to µBG, the analysis 
of morphology on nBG showed similar results (Fig. 7 c)). No obvious effect could be detected 
on cells during the cultivation with nanosized BG particles. However, at the highest 
concentration of nBG (200 µg ml-1) agglomerates can be even detected by LM. Vybrant™ 
cell-labeling was used to display the cells at higher magnifications. In Fig. 8 CLSM-images of 
MG-63 cultured with 200 µg ml-1 µBG and 200 µg ml-1 nBG and without contact to any BG 
particles were shown. With or without BG particles cells form their typical elongated and 
polygonal morphology, including cell-cell contacts. Even at this highest concentration of 200 
µg ml-1 no influence of BG particles on MG-63 cells could be found. Osteoblastic activity was 
investigated by means of specific ALP activity (Fig. 9). Measured ALP activity was 
comparable at all µBG concentrations, indicating a similar degree of osteoblastic activity. In 
addition, the cultivation of MG-63 cells on nBG induced an increase of specific ALP-activity, 
which was even significantly higher on concentration of 200 µg ml-1.  
4. Discussion 
4.1 As-prepared stage 
The nBG synthesized by flame spray synthesis was investigated in terms of their in vitro 
bioactivity and cell response. TEM and XRD analysis confirmed the amorphous structure of 
the as-fabricated nBG since no evidence of a crystalline phase is detected, comparable to an 
earlier study (Brunner et al. 2006). The nBG investigated in the present work exhibits chain-
like agglomerates.  
 
 
4.2 In vitro reactivity in SBF  
The reaction stages in the SBF monitored by FT-IR showed the presence of carbonate species 
on the µBG as well as nBG particles. For the as-received materials these compounds detected 
can be attributed to carbonate species adsorbed on the surface. The single peak at ~1460 cm-1 
indicates the presence of purely ionic carbonate-like structures with high symmetry which are 
likely adsorbed on the glass surface upon reaction with CO2 in air (Du et al. 2010; Cerruti and 
Morterra 2004). Interestingly, the intensity of this band is higher in the nBG sample than in 
the µBG and additionally the carbonate band at 871 cm-1 appears also in the initial state of the 
nBG sample which is likely due to the higher specific surface of the nanoscaled glass powder 
resulting in larger quantities of adsorbed species. After contact with liquid medium during the 
first stage of reaction in SBF, i.e. after 4 h (see Fig. 1 a) and Fig. 1 b)) the single peak at 1460  
cm-1 is split to a double peak related to asymmetric surface carbonate structures. Since it is 
known that the BG surface is depleted in Na+ and enriched with Ca2+ ions, through migration 
of the ionic species from the bulk glass to the surface, the change in CO32- symmetry is likely 
due to formation of calcium coordinated carbonate structures (Ca2+⋅⋅⋅CO32-) (Cerruti and 
Morterra 2004; Cerruti et al. 2005). However, the ν3(CO32-) modes represented as double peak 
(1420 cm-1 and 1480 cm-1) can be also attributed to carbonate ions substituted in apatite lattice 
(Koutsopoulos 2002). According to XRD analysis of the µBG, HAp formation takes place 
after 3d immersion in SBF. At the same stage there is a sharp increase of the intensity of the 
ν3(CO32-) modes and additionally the ν2(CO32-) mode appears, which is related to carbonate 
ions incorporated in HAp. It is suggested that as soon as HAp forms on the glass particle 
surface the detected carbonate species are dominated by carbonate ions replacing phosphate 
groups in the HAp lattice. For the nBG samples it is difficult to distinguish between the 
different carbonate species from the IR spectra since the ν2(CO32-) band is present for the as-
received sample and the reaction of the nanoscaled bioactive glass occurs rapidly making it 
challenging to detect any changes in the IR bands related to carbonate species. However, we 
assume that the mechanism for this transformation is valid as for µBG described above. In the 
next step a silica gel layer is formed on the bioactive glass surfaces (both nBG and µBG) form 
through condensation reaction of SiOH groups (Hench 1991):   
2!"#$   !" − ! − !" + !!!         (2) 
Further, an amorphous calcium phosphate layer (ACP) as a precursor phase to hydroxyapatite 
is formed (Hench 1998; Cerruti et al. 2005; Jones et al. 2001; Dey et al. 2010). For the nBG 
the in vitro reactivity is enhanced compared to µBG since all stages of reaction in SBF 
including the silica gel and ACP formations as well as HAp crystallisation occur faster (see 
Table 4). It is well known that SBF and related physiological media are supersaturated in 
respect to several calcium phosphate phases (Zhu et al. 2003; Müller and Müller 2006). The 
thermodynamic driving force ΔG for crystallisation of a solid phase from aqueous solution 
can be expressed using the supersaturation S according to following equation: ∆! = − !"! ln  (!)           (3) 
Here R, T and n are the universal gas constant, temperature and number of ions present in the 
solution, respectively. The supersaturation of a solution S can be calculated using equation (4) 
with IP, Ksp and n being the ionic product activity, the solubility product and the number of 
ions of the formula, respectively (Nielsen 1984): 
! = !"!!"!                (4) 
The supersaturation of a stoichiometric hydroxyapatite (HA, Ca10(PO4)6(OH)2), an A-type 
carbonated hydroxyapatite (A-CHA, Ca10(PO4)6(CO3)0,5(OH)), a B-type (B-CHA, 
Ca9(HPO4)6(PO4)5(CO3)0,5(OH)) carbonated apatite and calcite (CaCO3) were calculated 
according to the equations 5-8 (Müller and Müller 2006): !"!" = !"!! !" !"!!! ![!"!]!!!!!!!"!!!      (5) !"!!!"# = !"!! !" !"!!! !.! !"!!! ![!"!]!!!!!".!!!!        (6) !"!!!"# = !"!! !" !!"!!! !.! !"!!! !.! !"!!! ! !"! !!!!!".!!!!    (7) 
!"!"#$%&' = !"!! [!"!!!]!!!          (8) 
The activity coefficient yz of an ion with the valence z were calculated using a modified 
Debey-Hückel equation as proposed by Davis and Shedlovsky (1964): −!"#!! = 0.515!![ ! 1+ ! − 0.3!        (9) 
Here I is the total ionic strength of the solution and is given by: ! = 0.5 !!!!!         (10) 
with zi and ci being the charge and the concentration of the i ion, respectively.  
The CO32- and the PO43- concentration were calculated from the ion concentrations given in 
Table 1 and from the equilibrium constants for the reactions (11) and (12) (Müller and Müller 
2006): 
!"#!! + !"!      !"!!! +   !!!    !" = 10.25      (11) !"#!!!   !!!!! + !!    !" = 12.19          (12) 
The IP and the degree of supersaturation for the phases mentioned above are given in Table 5.  
For the precipitation of any solid phase to occur the free Gibbs energy ΔG must be <0 which 
requires S >1. The SBF is supersaturated for stoichiometric hydroxyapatite as well as for 
carbonated apatites. Moreover, the highest supersaturation is obtained for B-type carbonated 
apatite, whereby the carbonate ions are incorporated into the apatite lattice by substituting 
PO43- ions (Elliot 1994). Even though the difference in supersaturation between A and B-type 
apatite is insignificant, the formation of B-type carbonate is thermodynamically favored for 
precipitation in the SBF used. It has been previously shown that B-type substitution is the 
dominating mechanism for carbonated apatites especially for SBF solution with lower HCO3-
content (Müller and Müller 2006; Antonakos et al. 2007). The FT-IR analysis also confirms 
B-type substitution since the characteristic ν3(CO32-) band at 1450 cm-1 for A-type substituted 
apatite was not observed in the IR-spectra (Koutsopoulos 2002). Moreover, the nanosized 
characteristics of the CHAp observed by XRD and TEM analyses are typical for biomimetic 
hydroxyapatite formed in physiological media (Müller and Müller 2006; Pasteris et al. 2004). 
TEM investigations revealed nanocrystalline HAp being present within compact agglomerates 
after immersion for 1 and 7 days in SBF, also coexisting with unreacted nBG. Furthermore, 
the reduction of the size of the primary bioactive glass nanoparticles is observed after 
immersion in SBF solution, which indicates the dissolution of nBG and distortion of the 
chain-like network of the nBG, as discussed above. 
Labbaf et al. (2011) investigated submicron spherical bioactive glass particles with the 
composition 85 mol% SiO2 and 15 mol% CaO by means of TEM. The particles were 
produced by the sol-gel process with a mean particle diameter of 250 nm. They found 
formation of HAp after 5 days immersion in SBF. Hereby, the authors also proposed 
significant dissolution of the bioactive glass particles and formation of nanoscaled HAp. 
However, it is difficult to directly compare our study with this work, due to the noted 
differences in particle size and composition. For instance, in our case the formation of HAp is 
already observed after 1 day of immersion in SBF by means of TEM, which supports the fact 
that the reduced particle size of the present nBG compared to the particles investigated by 
Labbaf et al. (2011) and thus the increased specific surface area significantly increases the 
potential of the material to form HAp. The high reactivity of nanoparticles confirmed through 
the very fast formation of CHAp might be also affected by the non uniform structure, 
morphology and relatively high porosity of the as-prepared nBG, observed by TEM (see Fig. 
3 a) and b)). Tilocca (2011) showed in molecular dynamic simulations of Bioglass® 
nanoparticles that the Na+/Ca2+ ratio is increased for nanoparticles compared to bulk material 
and that the network connectivity is reduced, indicated through higher Q1 and lower degree of 
Q3 units. Moreover, the mobility of Na+ ions is increased in the nanoparticles. Since these 
features are known to accelerate the dissolution behaviour of 45S5 bioactive glass via rapid 
release of Na+ ions and exchange with H+ from the physiological environment they might also 
explain the enhanced bioactivity of the nBG nanoparticles. An increased reactivity by 
reduction of the particle size and thus an increase of the specific surface area has been 
observed by several researchers for the 45S5-type bioactive glass. Sepulveda et al. (2002) 
investigated the effect of powder type, particle size (50 – 20 µm (fine size); 90 – 300 µm 
(medium size); 90 – 710 µm (coarse size)), and type of dissolution medium on the dissolution 
behaviour of bioactive glasses by means of in vitro testing using melt-derived 45S5-type and 
sol-gel derived 58S bioactive glass powders. The specific surface area of the fine-sized 
particles was 2.7 m2g-1, 0.24 m2g-1 for the medium-sized particles, and 0.15 m2g-1 for the 
coarse-sized particles, respectively. Amongst other observations, they found that the 
dissolution and thus the reactivity of the melt-derived 45S5-type bioactive glass is 
significantly increased for the finer particles ranging from 5 to 20 µm, compared to the more 
coarse particles ranging from 90 to 710 µm. Although Sepulveda et al. (2002) did not 
investigate nanometric particles their results support the here presented findings and the fact 
that a clear trend of higher reactivity can be achieved by reducing the particle size (increasing 
the specific surface area).  
According to Table 5 SBF is undersaturated for calcite precluding the nucleation of calcite in 
the SBF. Indeed, no calcite formation was found for the micron-sized bioactive glass particles 
at any stages of reaction in SBF, as proved by FT-IR and XRD analyses. For the nanoscaled 
bioactive glass particles, however, formation of nanosized and large calcite crystals (≥ 100 
nm) was observed by TEM already after 1 day (and 7 days) in SBF, while large calcite 
crystals are detected by XRD and FT-IR not until 3 days of immersion in SBF. Bioactivity 
tests in SBF solution revealed the formation of two crystalline phases, calcite and HAp. The 
high Ca/P peak intensity ratio of ~12, as observed by TEM EDX spectroscopy after 
immersion for 7 days in SBF, is likely due to the large amounts of calcite precipitations. TEM 
observations revealed the formation of HAp and calcite already after 1 day immersion in SBF, 
while XRD and FTIR revealed the formation of HAp starting from day 3 in SBF. This 
suggests that the amount of HAp and calcite precipitates is not strongly pronounced after 
immersion for 1 day in SBF and thus HAp and calcite are not detectable by XRD and FTIR, 
in those samples, Fig. 1 b) and Fig. 2 b). Moreover, it is worth mentioning that no calcite 
formation was found on micron-sized glass particles, which might be attributed to the effect 
of particle size. Jones et al. (2001) observed calcite formation for 45S5 bioactive glass powder 
particles after 2h of immersion in SBF. It was found that calcite is forming at the expense of 
HAp for high BG powder concentrations in the SBF solution, likely due to an excessive 
amount of calcium ions released in the SBF resulting in a higher Ca/P ratio and a pH shift in 
the SBF solution. This mechanism favoured the precipitation of calcite. Oyane et al. (2003) 
investigated the formation and growth of CaCO3 clusters in different simulated body fluids. 
They have shown that SBF solutions depleted in PO43- ions and thus high Ca/P ratio can 
accelerate the precipitation of calcite by increasing the saturation of the solution in respect to 
calcite. This early HAp formation agrees very well with our TEM results. Moreover, our 
results indicate that the calcite formation on nBG is likely due to the large surface area of the 
particles resulting in a high reactivity of the glass surface and enhanced diffusion of Ca ions 
in the glass network. Mozafari et al. (2010) also observed co-precipitation of calcite beside of 
hydroxyapatite on mesoporous sol gel derived bioactive glass after 1d of soaking in SBF 
which was related to the high surface area (~140 m2 g-1) and nano-porosity of these particles. 
They proposed that the high surface area allows the high release of calcium (Mozafari et al. 
2010). According to the findings in the literature discussed above, the calcite precipitation 
takes place parallel to the hydroxyapatite formation during the first stages of SBF reactions. 
Even though the crystalline calcite phase was not detected by FT-IR and XRD until 3 days in 
SBF, TEM clearly revealed calcite precipitates already formed after 1d in SBF. Thus, we 
postulate that the calcite nucleation occurs as co-nucleation at very early stages of nBG 
reaction in SBF. It has been shown previously that the precipitation of calcite is preceded by 
formation of an amorphous carbonate cluster (ACC) as a precursor phase (Pichon et al. 2008) 
which is obviously not seen in the XRD spectrum. Moreover, indicated through the large 
crystalline size of calcite particle the diffusion driven crystal growth of the calcite phase 
might need longer time not becoming detectable until 3d of reaction in SBF. Based on our 
results and the findings in the literature, the following model can be suggested for the 
reactions occurring at the surface of nBG when exposed to simulated body fluid, as shown in 
Fig. 10:  
• Stage 1 (4h-8h): Dissolution of nBG particles and release of ionic species (e.g. Ca2+, 
Na+, PO43-). The network of primary particles is distorted and the particle size is 
reduced. Silica layer is formed by condensation of Si-OH groups. Ca2+ and PO43- ions 
diffuse through the silica layer forming an amorphous CaP layer (ACP) (Hench 1998). 
Co-nucleation of an amorphous Calcium-carbonate as precursor phase for calcite 
occurs.  
• Stage 2 (1d): Forming of a 3D silica network and crystallisation of nanocrystalline (5-
20 nm) carbonated HAp (type B substitution) and co precipitation of calcite. Three 
independent structural configurations are formed: i) unreacted nBG with 
nanocrystalline HAp ii) unreacted nBG with nanocrystalline HA and calcite co-
precipitates and iii) unreacted nBG with single-crystalline calcite precipitates. 
• Stage 3 (3-7d): Further co-precipitation and growth of larger calcite crystals (≥ 100 
nm) at the expense of carbonated hydroxyapatite (CHA). Finally, separated 
configurations of i) nBG and nanocrystalline HAp and ii) nBG and single-crystalline 
calcite are present. 
As in the present study, for the same nanosized 45S5 bioactive glass particles, Brunner et al. 
(2006) observed HAp formation by means of Raman spectroscopy and scanning electron 
microscopy after immersion of nBG pellets for 7 days in SBF. HAp nanocrystals covering the 
rough surface of bioactive 45S5 glass pressed tablets were observed. However, the specific 
effect of the nanosized particles was only partially investigated by pressing the glass powder 
to dense bulk samples. Thus, the reactions kinetics of the nBG are different since, clearly, the 
reactivity of single nanoscaled particles is expected to be higher due to the high surface area, 
as shown in the present work. In the present study, however, HAp formation was investigated 
by XRD, FTIR and TEM after immersion of the as-prepared nBG powder in SBF for different 
time points ranging from 4 h to 7 d, monitoring in detail for the first time the reaction kinetics 
in nBG. Moreover, a formation of calcite was detected, likely due to the high surface area of 
the particles, which was not considered by Brunner et al. (2006) in the experiments with bulk 
materials. Unlike bulk materials, the bioactivity of small particles strongly depends on their 
size and specific surface area (Sepulveda et al. 2002), which is shown in the present work as a 
fundamental and comparative study.  
4.3 Cytocompatibility 
In this study ZnO, µBG and nBG particles at the concentrations of 0.1 - 200 µg ml-1 were 
incubated with MG-63 osteoblastic cells over 48 h. All materials were pre-treated in the same 
way and incubated with the same amount of cells at the same cultivation period. Afterwards 
cell amount, viability and morphology as well as spec. ALP-activity were analysed. Heng et 
al. (2011) determined the cytotoxicity effect of ZnO particles and also of Zn2+ ions according 
to cell type, seeding concentration and surface area of the culture well. They showed the 
importance of the design of the in vitro experiments to measure the cytotoxicity of 
nanoparticles. Therefore, ZnO particles with a particle size of 0.5-1.5 µm and a specific 
surface of 6.5 m2 g-1 were used as a reference sample. The detected cytotoxicity of ZnO 
particles analysed with 100.000 cells over 48 h of incubation ranged in the concentrations 
between ~ 31 and 41 µg ml-1. These results correspond to the findings of Gann et al. (2010), 
who showed cytotoxic effects of ZnO particles at concentrations of 31.5 - 62.5 µg ml-1.  
Regarding both BG types, no cytotoxic effect was determined even by an increase of particle 
concentration (see Fig. 6). Although the concentration of BG particles being kept constant, the 
use of nanosized BG will increase the particle surface to cell area ratio dramatically 
(compared to the constant MG-63 cell shape with an area of ~ 950 µm² and a volume 1.3 10³ 
µm³) which is expected to lead to a different cell response. 
It should be also considered that the nanosized particles undergo sedimentation and 
agglomeration before cell seeding. Despite this limitation, it is interesting that nBG induced 
higher activities of MG-63 cells after 48 h of incubation compared to µBG. Even at a higher 
concentration of 1000 µg ml-1 of nBG a remaining cell viability of 81 % was measured (data 
not shown). In contrast to our results (with particle size of 20 - 40 nm and specific surface 
area of ~70 m2 g-1), Labbaf et al. (2011) determined a reduction of hMSC viability to 85 % 
after being in contact wirth sub-micron sized bioactive glass particles at a concentration of 
200 µg ml-1. These sol-gel derived particles exhibit a size in the range of 175 - 250 nm and 
with a specific surface area of 28 m2 g-1 (Labbaf et al. 2011). Other nanosized biomaterials 
like TiO2 influenced also the cell viability. Gerhardt et al. (2007) measured a decrease of MG-
63 cell viability of 65 % by the use TiO2 particles (size 21 nm, specific surface area 50 m²g) 
with a concentration of 250 µg ml-1 after 24 h. Beside the material composition, the size of the 
particles clearly influences cell - biomaterial - interaction. The size effect was shown by Shi et 
al. (2009), comparing hydroxyapatite particles in the range of 20, 80 and 500 nm. HAp 
particles of 20 nm size were seen to support cell proliferation and inhibit apoptosis in MG-63 
osteoblast-like cells. Our in vitro studies suggest also an increase of cell activity caused by the 
use of nanosized BG compared to the microsized particles. One reason could be that bioactive 
glass dissolution products have been shown to upregulate a number of genes in several cell 
types and above all in osteoblasts (Jell and Stevens 2006). Especially, BG degradation 
products like Si and P can influence ALP. Given the positive results of the present 
investigation, future work will consider the long term influence of nBG and its dissolution 
products on osteoblast-like cells and on the differentiation behaviour of precursor cells. 
 
 
5. Conclusion  
 
Our study represents a novel detailed observation of physico-chemical reactions occurring on 
nanoscaled bioactive 45S5 (nBG) particles in simulated body fluid (SBF). XRD, FT-IR and 
TEM investigations revealed a very rapid formation of carbonated nanocrystalline 
hydroxyapatite after 1d of immersion in SBF. The initial network of agglomerated primary 
nanoscaled particles was shown to be distorted and the particle size is reduced upon the 
dissolution process. Furthermore, nBG particles co-precipitation of nanocrystalline and large 
calcite was observed by TEM after 1 day likely due to the higher surface area and, thus, 
higher reactivity of the nBG particles in comparison to conventional (µBG) particles. These 
findings bring new insight in the reactions kinetics of nanoscaled 45S5 bioactive glass 
particles which are relevant for applications of nBG in tissue engineering and for 
considerations for in vitro cells test carried out on this material. Furthermore, the in vitro 
investigation with MG-63 osteoblast-like cells revealed a high cytocompatibility of the nBG 
particles compared to µBG. It seems that particles size and material composition enhanced 
cell growth and activity. Thus, the nanoscaled 45S5 bioactive glass particles can be 
considered as well promising material for bone tissue engineering, providing very fast kinetics 
for bone-like hydroxyapatite mineralisation without any toxic effects on osteoblast cells.  
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Figure captions: 
 
Table 1: Properties of the materials used in the study. 
 
Table 2: Chemical composition of the melt-derived and flame synthesized bioactive 45S5 
glass (in wt.%.). 
 
Table 3: Ion concentrations of the simulated body fluid (SBF) and human blood plasma 
(Boccaccini et al. 2010). 
 
Table 4: Overview over the main peaks detected in the FT-IR spectra of nBG and µBG prior 
and after soaking in SBF for different time points. 
 
Table 5: Ionic product and degree of supersaturation calculated for hydroxyapatite and calcite.  
 
Fig. 1: FTIR spectra of a) nanosized 45S5 bioactive glass particles (nBG) and b) micron-sized 
45S5 bioactive (µBG) glass particles: as-prepared and after immersion in SBF for 4h, 8h, 24h, 
3d and 7 d, respectively.  
 
Fig. 2: XRD spectra of a) nanosized 45S5 bioactive glass (nBG) and b) micron-sized 45S5 
bioactive glass (µBG) after immersion in SBF for 1d, 3d and 7d.  
 
Fig. 3: TEM images and selected area electron diffraction (SAED) patterns of nBG particles: 
a) and b) as-prepared, c) - f) after immersion for 1 day in SBF solution. After 1 day 
immersion in SBF the formation of nanocrystalline and large calcite precipitates and 
nanocrystalline HA is observed. 
 
Fig. 4: TEM images and selected area electron diffraction (SAED) patterns of nBG after 
immersion for 7 days in SBF: a) – d) nanocrystalline and large calcite precipitates, coexisting 
with unreacted nBG; e) and f) compact agglomerates composed of HA and unreacted nBG. 
 
Fig. 5: LDH-activity of MG-63 cell cultured on µBG, nBG and ZnO in the range of 0-200 µg 
ml-1 over 48 h (normalized in each case to 0 µg ml-1 = 100 %, * p < 0.05).  
 
Fig. 6: Mitochondrial activity MG-63 cell cultured on µBG, nBG and ZnO in the range of 0-
200 µg ml-1 over 48 h (normalized in each case to 0 µgml-1 = 100 %, * p < 0.05). 
 Fig. 7: LM-images of MG-63 cultured on a) ZnO particles b) on µBG particles and c) nBG 
particles in the range of 0-200 µg ml-1 for 48 h. 
 
Fig. 8: CLM-images of MG-63 cultured on 0 (left) 200 µg ml-1 µBG (centre) and 200 µg ml-1 
nBG (right) particles in the range of 0-200 µg ml-1 for 48 h. 
 
Fig. 9: Specific ALP-Activity of MG-63 cell cultured on µBG and nBG in the range of 0-200 
µg ml-1 over 48 h (normalized in each case to 0 µg ml-1 = 100 %, * p < 0.05).  
 
Fig. 10: Proposed model for HAp formation and co-precipitation of calcite on nanoscaled 
bioactive glass powder during immersion in SBF. 
 
 
 
 
  
Table 1 
Material Sample code Particle size  Specific surface (m2g-1) 
Melt-derived 45S5 glass µBG 10 µm 1-2 
Flame-synthesized 45S5 glass nBG 20-60 nm 60-80 
Zinc oxide ZnO 0.5-1.5 µm 6.5 
 
 
Table 2 
 SiO2 CaO Na2O P2O5 
nBG 47.8 25.1 22.6 4.6 
µBG 44.97 24.55 24.55 5.99 
 
 
Table 3 
 
Ion Na+ K+ Mg2+ Ca2+ Cl- HCO3- HPO42- SO42- 
Blood plasma 142 3,6-5,5 1 2,12 95-107 27 0,6-1,4 0.5 
SBF 142 5,0 1,5 2,5 148,8 4,2 1,0 0.5 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
Assignment Position (cm-1) and shape  Time point of appearance* Remarks Reference 
nBG µBG 
νsym(Si-O-Si) ~490-500 as-prepared state Shifted to 450 due to leaching of 
cations; νsym(Si-O-Si) at ~450 cm-
1is also observed for pure silica. 
(Cerruti et al. 
2005) 
(Bunker et al. 
1998) 
~450 all stages of reaction in SBF 
P-O band Broad band at ~560-610 4h 1d Characteristic band for amorphous 
calcium phosphate. 
(Cerruti et al. 
2005) 
ν4(P-O-P) Sharp double peak at 
~570 and ~600 
1d 3d Bending mode of P-O-P bond 
found in hydroxyapatite.  
(Koutsopoulos 
2002) 
CO32- Small peak at ~712 3d not 
visible 
Characteristic band for calcite. (Du et al. 2010) 
δ(Si-O-Si) Peak at ~800 
 
4h 3d 3D silica structures (Cerruti et al. 
2005) 
ν2(CO32) Sharp peak at ~871 permanent 3d Characteristic band for CO32-group 
in carbonated apatites. For nBG 
this band is related to both 
carbonates adsorbed on the surface 
and CO32- substituted in the apatite 
layer. See discussion. 
(Koutsopoulos 
2002) 
SiONBO Shoulder at ~930 as-prepared state The SiONBO is decreasing in 
intensity due to cation leaching. 
(Cerruti et al. 
2005; Bunker et al. 
1998) 
νasym(Si-O-Si) Intense broad band at 
~1020 
as-prepared state The broad complex band at 900-
1200 is difficult to analyse due to 
overlapping as both PO and SiO 
groups absorb in this region. 
(Cerruti et al. 
2005;Koutsopoulos 
2002) 
(Si-O-Si) 
bonds 
Shoulder at ~1210 all stages of reaction in SBF Formation of new Si-O-Si bonds 
upon condensation of SiOH 
groups. Appearance of this band 
corresponds to the decrease of the 
SiONBO peak.  
(Cerruti et al. 
2005; Jones et al. 
2001) 
ν3(CO32-) Broad peak at ~1460  as-prepared state Observed for symmetrically 
coordinated pure ionic carbonate 
ions adsorbed on surfaces. The 
intensity of the peak is higher for 
nBG compared to µBG. 
(Du et al. 2010; 
Cerruti and 
Morterra 2004)  
Double peak at ~1430 and 
~1500 
all stages of reaction in SBF These bands can be attributed 
either to Ca2+ coordinated CO32- 
adsorption [29-30] or carbonate 
ions substituted in carbonated 
apatites [26]. 
Please note: for µBG a sharp 
increase in intensity of this double 
peak after 3 d is attended by the 
appearance of the ν2(CO32) band at 
~871 cm-1. 
 
δ(H2O) Small peak at ~1630  all stages of reaction in SBF Coordinated water molecules 
adsorbed on the surface.  
(Cerruti et al. 
2005) 
*related to immersion in SBF 
 
  
Table 5 
Phase Formula -log(IP) S 
Stoichiometric hydroxyapatite, sHA Ca10(PO4)6(OH)2) 97.6 1.1 
Type-A carbonated hydroxyapatite, A-CHA Ca10(PO4)6(CO3)0,5(OH) 93.0 19.6 
Type B carbonated hydroxyapatite, B-CHA Ca9(HPO4)6(PO4)5(CO3)0,5(OH) 90.8 19,8 
Calcite CaCO3 22.8 8⋅10-8≅0 
IP=Ionic activity; S=Saturation of the SBF in respect to corresponding phase. Ksp values for HA, A-CHA, 
B-CHA and calcite were taken from Elliot et al. (1973), Ito et al. (1997), Tang et al. (2003), and Berner 
1976, respectively.  
 










